| P2093 | author name string | Ilaria Russo | |
| | Gaetano Lamberti | |
| | Carmine Vecchione | |
| | Ornella Piazza | |
| | Pio Zeppa | |
| | Anna Angela Barba | |
| | Sabrina Bochicchio | |
| | Cristina Bucci | |
| | Carolina Ciacci | |
| | Paola Iovino | |
| | Antonella Santonicola | |
| | Albino Carrizzo | |
| P2860 | cites work | Inflammation and cancer | Q24649640 |
| | Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian cancer | Q27851620 |
| | Cyclin D1 genetic heterozygosity regulates colonic epithelial cell differentiation and tumor number in ApcMin mice | Q28510765 |
| | Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells | Q31660362 |
| | Synthetic lethal therapy for KRAS mutant non-small-cell lung carcinoma with nanoparticle-mediated CDK4 siRNA delivery | Q33587012 |
| | siRNA Delivery Strategies: A Comprehensive Review of Recent Developments | Q33611947 |
| | Modulated expression of genes encoding estrogen metabolizing enzymes by G1-phase cyclin-dependent kinases 6 and 4 in human breast cancer cells | Q33645120 |
| | CDK4/6 and IGF1 receptor inhibitors synergize to suppress the growth of p16INK4A-deficient pancreatic cancers | Q34004428 |
| | MEN1 tumorigenesis in the pituitary and pancreatic islet requires Cdk4 but not Cdk2. | Q34054054 |
| | Basic and clinical aspects of osteoporosis in inflammatory bowel disease. | Q34225188 |
| | Reduced expression of SOX7 in ovarian cancer: a novel tumor suppressor through the Wnt/β-catenin signaling pathway | Q34233284 |
| | Ulcerative colitis and colorectal cancer. A population-based study | Q34634203 |
| | The role of pRB, p16 and cyclin D1 in colonic carcinogenesis. | Q34660111 |
| | Elevated expression of CDK4 in lung cancer | Q34980269 |
| | Radical causes of cancer. | Q35097371 |
| | The role of COX-2 in intestinal inflammation and colorectal cancer | Q35234704 |
| | Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia | Q35631212 |
| | COX-2 inhibition in cancer therapeutics: a field of controversy or a magic bullet? | Q35753467 |
| | Novel classes of non-coding RNAs and cancer | Q36209417 |
| | Cyclooxygenase-2 expression is positively associated with lymph node metastasis in nasopharyngeal carcinoma | Q36310570 |
| | The effects of particle size, density and shape on margination of nanoparticles in microcirculation | Q36488910 |
| | Effects of Nrf2 silencing on oxidative stress-associated intestinal carcinogenesis in mice | Q37045580 |
| | Colorectal carcinogenesis: Review of human and experimental animal studies | Q37183760 |
| | PKCalpha tumor suppression in the intestine is associated with transcriptional and translational inhibition of cyclin D1 | Q37290922 |
| | NF-kappaB as a critical link between inflammation and cancer | Q37412699 |
| | Treatment of extraintestinal manifestations in inflammatory bowel disease | Q38050884 |
| | RNA interference in the treatment of colon cancer | Q38095807 |
| | Gene therapy and DNA delivery systems | Q38167136 |
| | CDK2 and CDK4 play important roles in promoting the proliferation of SKOV3 ovarian carcinoma cells induced by tumor-associated macrophages | Q38202073 |
| | Liposomes as siRNA delivery vectors. | Q38346431 |
| | Tracheal and bronchial involvement in colitis ulcerosa - a colo-bronchitic syndrome? A case report and some additional considerations | Q38401205 |
| | Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease | Q38404877 |
| | Regulation of the retinoblastoma-E2F pathway by the ubiquitin-proteasome system | Q38576213 |
| | Cyclin-Dependent Kinases as Coregulators of Inflammatory Gene Expression | Q38683666 |
| | In vitro and ex vivo delivery of tailored siRNA-nanoliposomes for E2F1 silencing as a potential therapy for colorectal cancer | Q38758480 |
| | Anti-tumor effect via passive anti-angiogenesis of PEGylated liposomes encapsulating doxorubicin in drug resistant tumors. | Q38767987 |
| | Knockdown of zinc transporter ZIP5 (SLC39A5) expression significantly inhibits human esophageal cancer progression | Q38857951 |
| | The culture of gut explants: A model to study the mucosal response | Q38913666 |
| | Formononetin promotes cell cycle arrest via downregulation of Akt/Cyclin D1/CDK4 in human prostate cancer cells | Q38949250 |
| | Cyclin D1, cancer progression, and opportunities in cancer treatment. | Q38970431 |
| | Thrombosis in the setting of obesity or inflammatory bowel disease. | Q39027731 |
| | Crohn Disease: Epidemiology, Diagnosis, and Management | Q39364285 |
| | Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid | Q39722033 |
| | Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells | Q39736048 |
| | Differential regulation of D-type cyclins in the mouse intestine | Q40339492 |
| | Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer | Q42152237 |
| | Cyclin D1 Gene Silencing by siRNA in Ex Vivo Human Tissue Cultures. | Q42493126 |
| | Ultrasonic energy in liposome production: process modelling and size calculation. | Q47178064 |
| | Risk of ischemic stroke in patients with Crohn's disease: a population-based nested case-control study | Q48377738 |
| | Cell-Cycle Therapeutics Come of Age. | Q50959563 |
| | Increased expression of the cyclin D1 gene in Barrett's esophagus. | Q51013274 |
| | Chronic inflammation promotes retinoblastoma protein hyperphosphorylation and E2F1 activation. | Q53353383 |
| | Ulcerative Colitis | Q55922642 |
| | Wnt pathway-related gene expression during malignant progression in ulcerative colitis | Q62977731 |
| | Cyclin D1 is not an essential target of beta-catenin signaling during intestinal tumorigenesis, but it may act as a modifier of disease severity in multiple intestinal neoplasia (Min) mice | Q74620394 |
| | Activation of B-Myb by E2F1 in hepatocellular carcinoma | Q81636226 |
| | Downregulation of MSP58 inhibits growth of human colorectal cancer cells via regulation of the cyclin D1-cyclin-dependent kinase 4-p21 pathway | Q84113358 |
| | Ocular manifestations of inflammatory bowel disease | Q88247623 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P304 | page(s) | 25-33 | |
| P577 | publication date | 2017-07-01 | |
| P1433 | published in | Translational medicine @ UniSa | Q27724979 |
| P1476 | title | siRNA Delivery for Control of Cyclin D1 and E2F1 Expression in Crohn's Disease | |
| P478 | volume | 17 | |